To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagnostic certainty categories of amyotrophic lateral sclerosis (ALS).status: publishe
Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, w...
To allow early diagnosis and monitoring of disease progression, there is a need for biomarkers in am...
There is a need for biomarkers for amyotrophic lateral sclerosis (ALS), to support the diagnosis of ...
OBJECTIVE: To examine neurofilament (Nf) concentrations according to symptom onset and clinical diag...
Item does not contain fulltextOBJECTIVE: To examine neurofilament (Nf) concentrations according to s...
Objective To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagn...
Objective To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagn...
Objective To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagn...
Objective:andnbsp;To examine Nf concentrations according to symptom onset and clinical diagnostic ce...
Objective: To examine Nf concentrations according to symptom onset and clinical diagnostic certainty...
OBJECTIVE: Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (AL...
OBJECTIVE: Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (AL...
OBJECTIVE: Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (AL...
Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, w...
OBJECTIVE: To determine the diagnostic performance and prognostic value of phosphorylated neurofilam...
Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, w...
To allow early diagnosis and monitoring of disease progression, there is a need for biomarkers in am...
There is a need for biomarkers for amyotrophic lateral sclerosis (ALS), to support the diagnosis of ...
OBJECTIVE: To examine neurofilament (Nf) concentrations according to symptom onset and clinical diag...
Item does not contain fulltextOBJECTIVE: To examine neurofilament (Nf) concentrations according to s...
Objective To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagn...
Objective To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagn...
Objective To examine neurofilament (Nf) concentrations according to symptom onset and clinical diagn...
Objective:andnbsp;To examine Nf concentrations according to symptom onset and clinical diagnostic ce...
Objective: To examine Nf concentrations according to symptom onset and clinical diagnostic certainty...
OBJECTIVE: Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (AL...
OBJECTIVE: Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (AL...
OBJECTIVE: Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (AL...
Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, w...
OBJECTIVE: To determine the diagnostic performance and prognostic value of phosphorylated neurofilam...
Neurofilaments are leading neurochemical biomarkers for amyotrophic lateral sclerosis (ALS). Here, w...
To allow early diagnosis and monitoring of disease progression, there is a need for biomarkers in am...
There is a need for biomarkers for amyotrophic lateral sclerosis (ALS), to support the diagnosis of ...